296 related articles for article (PubMed ID: 37196763)
1. An Inflection Point in Cancer Protein Biomarkers: What was and What's Next.
Barker AD; Alba MM; Mallick P; Agus DB; Lee JSH
Mol Cell Proteomics; 2023 Jul; 22(7):100569. PubMed ID: 37196763
[TBL] [Abstract][Full Text] [Related]
2. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
3. Artificial intelligence-based multi-omics analysis fuels cancer precision medicine.
He X; Liu X; Zuo F; Shi H; Jing J
Semin Cancer Biol; 2023 Jan; 88():187-200. PubMed ID: 36596352
[TBL] [Abstract][Full Text] [Related]
4. Artificial intelligence and digital biomarker in precision pathology guiding immune therapy selection and precision oncology.
Huss R; Raffler J; Märkl B
Cancer Rep (Hoboken); 2023 Jul; 6(7):e1796. PubMed ID: 36813293
[TBL] [Abstract][Full Text] [Related]
5. Are innovation and new technologies in precision medicine paving a new era in patients centric care?
Seyhan AA; Carini C
J Transl Med; 2019 Apr; 17(1):114. PubMed ID: 30953518
[TBL] [Abstract][Full Text] [Related]
6. Artificial intelligence in early drug discovery enabling precision medicine.
Boniolo F; Dorigatti E; Ohnmacht AJ; Saur D; Schubert B; Menden MP
Expert Opin Drug Discov; 2021 Sep; 16(9):991-1007. PubMed ID: 34075855
[No Abstract] [Full Text] [Related]
7. The Essentials of Multiomics.
Marshall JL; Peshkin BN; Yoshino T; Vowinckel J; Danielsen HE; Melino G; Tsamardinos I; Haudenschild C; Kerr DJ; Sampaio C; Rha SY; FitzGerald KT; Holland EC; Gallagher D; Garcia-Foncillas J; Juhl H
Oncologist; 2022 Apr; 27(4):272-284. PubMed ID: 35380712
[TBL] [Abstract][Full Text] [Related]
8. Future of biomarker evaluation in the realm of artificial intelligence algorithms: application in improved therapeutic stratification of patients with breast and prostate cancer.
Fitzgerald J; Higgins D; Mazo Vargas C; Watson W; Mooney C; Rahman A; Aspell N; Connolly A; Aura Gonzalez C; Gallagher W
J Clin Pathol; 2021 Jul; 74(7):429-434. PubMed ID: 34117103
[TBL] [Abstract][Full Text] [Related]
9. Towards artificial intelligence to multi-omics characterization of tumor heterogeneity in esophageal cancer.
Li J; Li L; You P; Wei Y; Xu B
Semin Cancer Biol; 2023 Jun; 91():35-49. PubMed ID: 36868394
[TBL] [Abstract][Full Text] [Related]
10. Biomarkers for personalized oncology: recent advances and future challenges.
Kalia M
Metabolism; 2015 Mar; 64(3 Suppl 1):S16-21. PubMed ID: 25468140
[TBL] [Abstract][Full Text] [Related]
11. Identifying Molecular Biomarkers for Diseases With Machine Learning Based on Integrative Omics.
Shi K; Lin W; Zhao XM
IEEE/ACM Trans Comput Biol Bioinform; 2021; 18(6):2514-2525. PubMed ID: 32305934
[TBL] [Abstract][Full Text] [Related]
12. Precision immunoprofiling by image analysis and artificial intelligence.
Koelzer VH; Sirinukunwattana K; Rittscher J; Mertz KD
Virchows Arch; 2019 Apr; 474(4):511-522. PubMed ID: 30470933
[TBL] [Abstract][Full Text] [Related]
13. The promising role of new molecular biomarkers in prostate cancer: from coding and non-coding genes to artificial intelligence approaches.
Alarcón-Zendejas AP; Scavuzzo A; Jiménez-Ríos MA; Álvarez-Gómez RM; Montiel-Manríquez R; Castro-Hernández C; Jiménez-Dávila MA; Pérez-Montiel D; González-Barrios R; Jiménez-Trejo F; Arriaga-Canon C; Herrera LA
Prostate Cancer Prostatic Dis; 2022 Sep; 25(3):431-443. PubMed ID: 35422101
[TBL] [Abstract][Full Text] [Related]
14. Clinical trial design in the era of precision medicine.
Fountzilas E; Tsimberidou AM; Vo HH; Kurzrock R
Genome Med; 2022 Aug; 14(1):101. PubMed ID: 36045401
[TBL] [Abstract][Full Text] [Related]
15. Omics-Based Investigations of Breast Cancer.
Neagu AN; Whitham D; Bruno P; Morrissiey H; Darie CA; Darie CC
Molecules; 2023 Jun; 28(12):. PubMed ID: 37375323
[TBL] [Abstract][Full Text] [Related]
16. Development of biomarkers to chart all Alzheimer's disease stages: the royal road to cutting the therapeutic Gordian Knot.
Hampel H; Lista S; Khachaturian ZS
Alzheimers Dement; 2012 Jul; 8(4):312-36. PubMed ID: 22748938
[TBL] [Abstract][Full Text] [Related]
17. Proteomic Profiling and Artificial Intelligence for Hepatocellular Carcinoma Translational Medicine.
Moldogazieva NT; Mokhosoev IM; Zavadskiy SP; Terentiev AA
Biomedicines; 2021 Feb; 9(2):. PubMed ID: 33562077
[TBL] [Abstract][Full Text] [Related]
18. New cancer biomarkers deriving from NCI early detection research.
Verma M; Srivastava S
Recent Results Cancer Res; 2003; 163():72-84; discussion 264-6. PubMed ID: 12903844
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
